The Penn Diabetes Research Center (DRC) participates in the nationwide interdisciplinary program established over three decades ago by the NIDDK to foster research in diabetes and related metabolic disorders. The mission of the Penn DRC is to support and develop successful approaches to the prevention, treatment, and cure of diabetes mellitus. Located at and administered by the University of Pennsylvania, the Penn DRC serves over 110 diabetes-oriented investigators, primarily from Penn's Perelman School of Medicine but also from other Schools within the University as well as collaborating Philadelphia institutions including Thomas Jefferson University, Temple University School of Medicine, the Monell Chemical Senses Center, and the Wistar Institute. The Penn DERC is highly interactive and interdisciplinary, representing many basic science and clinical departments. The Research Base of the Penn DRC is organized in 4 focus groups: 1) Beta Cell Physiology and Pathology;2) Signaling by Insulin and Other Hormones;3) Obesity;and 4) Cardiovascular Metabolism and Complications. The Penn DRC facilitates and supports diabetes research in a variety of ways. Six Biomedical Research Cores facilitate the work of Penn DRC investigators: Functional Genomics Core;Islet Cell Biology Core;Mouse Phenotyping, Physiology, and Metabolism Core;Radioimmunoassay/Biomarkers Core;Transgenic and Chimeric Mouse Core;and Viral Vector Core. Collaborative research and application of emerging technologies to diabetes investigation are further promoted by the Regional Metabolomic Core at Princeton. A Pilot and Feasibility Grant Program that has been highly successful for over three decades serves to nurture new investigators and to foster new initiatives in diabetes research. A broad and intensive Enrichment Program organizes weekly Diabetes and Endocrinology Research seminars, special events, and an annual Spring Diabetes Symposium, all designed to enhance communication and collaboration of Penn DRC investigators while keeping them abreast of the latest discoveries. Penn DRC investigators mentor trainees at every level (undergraduate, predoctoral, and post-doctoral Ph.D., M.D., and combined M.D. /Ph.D), and the Enrichment Program provides a superb environment for training in diabetes research. The Biomedical Cores, Pilot and Feasibility Grant Program, and Enrichment Program are coordinated and publicized by an Administrative Component that governs the DRC. Its organizational structure, including the Director and Associate Director, Executive Committee, Committee of Core Directors, and external as well as internal advisory boards, functions to maintain the diabetes-related research at the Penn DRC at the forefront of biomedical science.

Public Health Relevance

It is estimated that 25.8 million people in the United States (8.3 percent of the population) currently have diabetes, and the rate is higher among the elderly and Hispanics, Native Americans, and African-Americans. The mission of the Penn Diabetes Research Center is to prevent and cure this devastating disease and its complications through interdisciplinary basic and translational research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK019525-37
Application #
8469468
Study Section
Special Emphasis Panel (ZDK1-GRB-S (J1))
Program Officer
Hyde, James F
Project Start
1997-03-01
Project End
2017-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
37
Fiscal Year
2013
Total Cost
$1,821,831
Indirect Cost
$565,801
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ibrahim, Fadia; Maragkakis, Manolis; Alexiou, Panagiotis et al. (2018) Ribothrypsis, a novel process of canonical mRNA decay, mediates ribosome-phased mRNA endonucleolysis. Nat Struct Mol Biol 25:302-310
Cooney, Laura G; Milman, Lauren W; Hantsoo, Liisa et al. (2018) Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial. Fertil Steril 110:161-171.e1
Condon, David E; Tran, Phu V; Lien, Yu-Chin et al. (2018) Defiant: (DMRs: easy, fast, identification and ANnoTation) identifies differentially Methylated regions from iron-deficient rat hippocampus. BMC Bioinformatics 19:31
Correnti, Jason M; Gottshall, Lauren; Lin, Annie et al. (2018) Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells. Sci Rep 8:12923
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Qiu, Chengxiang; Huang, Shizheng; Park, Jihwan et al. (2018) Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med 24:1721-1731
Cohen, Daniel M; Lim, Hee-Woong; Won, Kyoung-Jae et al. (2018) Shared nucleotide flanks confer transcriptional competency to bZip core motifs. Nucleic Acids Res 46:8371-8384
Davila, Antonio; Liu, Ling; Chellappa, Karthikeyani et al. (2018) Nicotinamide adenine dinucleotide is transported into mammalian mitochondria. Elife 7:
Abu-Gazala, Samir; Horwitz, Elad; Ben-Haroush Schyr, Rachel et al. (2018) Sleeve Gastrectomy Improves Glycemia Independent of Weight Loss by Restoring Hepatic Insulin Sensitivity. Diabetes 67:1079-1085
Zhao, Juanjuan; Lupino, Katherine; Wilkins, Benjamin J et al. (2018) Genomic integration of ERR?-HNF1? regulates renal bioenergetics and prevents chronic kidney disease. Proc Natl Acad Sci U S A 115:E4910-E4919

Showing the most recent 10 out of 720 publications